Simris Group AB (PUBL) (STO:SIMRIS.B)
Sweden · Delayed Price · Currency is SEK 0.1150
-0.0075 (-6.12%)
Oct 13, 2026, 1:20 PM CET
Simris Group AB (PUBL) Market Cap
Simris Group AB (PUBL) has a market cap or net worth of 155.23 million as of October 12, 2026. It is the 38,448th most valuable company in the world and the 536th biggest in Sweden. Its market cap has increased by 93.23% in one year.
Market Cap
155.23M
Enterprise Value
147.24M
Revenue
1.39M
Global Rank
Country Rank
#536 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 22, 2016, Simris Group AB (PUBL)'s market cap has increased from 122.27M to 155.23M, an increase of 26.95%. That is a compound annual growth rate of 2.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 155.23M | 480.15% |
| Dec 30, 2025 | 26.76M | 0.88% |
| Dec 30, 2024 | 26.52M | -66.13% |
| Dec 29, 2023 | 78.32M | 72.71% |
| Dec 30, 2022 | 45.35M | -21.98% |
| Dec 30, 2021 | 58.12M | 3.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 183.86M |
| Xintela AB | 154.60M |
| Diamyd Medical AB | 151.88M |
| Abera Bioscience AB | 140.62M |
| Alzinova AB | 133.45M |
| NextCell Pharma AB | 127.91M |
| Initiator Pharma | 123.22M |
| OncoZenge AB | 115.37M |